Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Skylines and Oncology Headlines in Chicago for ASCO 2023

June 19, 2023 | Medscape Oncology, medical education 

- PMLiVE

ASCO 2023 was a huge success for Medscape Oncology with connections made with members and conference attendees during the event at the Medscape Oncology booth on the exhibit floor and through expert-led symposia held on three consecutive days.

For nearly 30 years, Medscape Oncology has been educating the community-based oncology care team and it is this deep expertise that fostered the collaboration with ASCO on an important educational initiative aimed at supporting high-quality cancer care and positive patient outcomes through education for the multidisciplinary members of the cancer care team.   The first track of this comprehensive initiative covers education topics for NSCLC including screening, treatment discussions, and palliative care along with ASCO resources to provide the tools clinicians need to help engage with their patients. You can read more about this here.

The Medscape Oncology symposia held during ASCO were all hybrid events that included an opportunity for virtual attendees to interact with leading experts and stay current on the latest developments in oncology. These symposia covered topics including Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer, Immunotherapy for the Treatment of Nonmelanoma Skin Cancers, and Genitourinary Cancers. While the hybrid approach to symposia is not new, what differentiates Medscape Oncology’s hybrid offering is Medscape’s ability to extend reach to learners via its vast social media network of over 3.1 million followers across all its platforms. This social outreach resulted in thousands of healthcare professionals accessing vital education content in a convenient and easily accessible manner.

In addition, Medscape Oncology hosted a networking event at the VU Rooftop Bar in Chicago, where faculty and attendees could meet to discuss the latest in oncology care and the need for education to help improve clinical practice and advance patient outcomes.

“We always look forward to ASCO as one of the biggest, most impactful events in the oncology community. This year we were proud to present our educational symposia and meet with faculty and attendees to explore what’s coming next in this rapidly evolving field, as well as announce our exciting education initiative with ASCO itself,” said Christine Carey, Vice President, Medscape Oncology.

For more information on Medscape Oncology, please contact Christine Carey or Stephen Dunn.

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...